White to off white oval shaped lozenge plain on one side and debossed with as follows on the other side: Cherry: 2 mg (A501), 4 mg (A415).
Mint: 2 mg Mint (A516).
Nicotine, USP 2 mg (equivalent to 10 mg Nicotine Polacrilex).
Nicotine, USP 4 mg (equivalent to 20 mg Nicotine Polacrilex).
The lozenge is sugar free.
Used in the management of nicotine dependence.
Begin using this product on the patient's quit day. In order to successfully quit smoking with this treatment, the patient should completely stop smoking.
Use 1 lozenge when urge to smoke occurs; do not use more than 1 lozenge at a time. Do not use more than 1 lozenge per hour. Do not chew or swallow the lozenge.
Do not eat or drink while the patient has a lozenge in their mouth. Avoid drinking acidic beverages such as coffee or soda for 15 minutes prior to sucking the lozenge because they may affect the absorption of nicotine.
When starting treatment, 1 lozenge may be sucked every 1-2 hours. Most people suck 8-12 lozenges per day.
Do not use more than 5 lozenges in 6 hours. Do not use more than 20 lozenges per day.
If an adverse event occurs with the use of the higher dose form of Nicotine Polacrilex Mini Lozenge, it is recommended to use the lower dose form or consult a healthcare professional.
Duration of use: For best results, the patient is recommended to complete the 12-week treatment course. If the patient is still using the lozenge after 12 weeks, the patient should gradually reduce the nicotine dose and discontinue when the dose has been reduced to 1-2 pieces/day. If the patient is still using nicotine lozenge after 6 months, talk to a healthcare professional for advice.
Nicotine Polacrilex Mini Lozenge sucking technique: One lozenge should be placed in the mouth and allowed to dissolve. Periodically, the lozenge should be moved from one side of the mouth to the other and repeated until the lozenge is completely dissolved (approximately 20-30 minutes for lozenges). Sucking the lozenge slowly can help to overcome some of the side effects. The lozenge must not be chewed or swallowed. Users should not eat or drink while a lozenge is in the mouth.
What should the patient do if they miss a dose: Continue medication based on dosage and/or consult a doctor.
Pale skin, increased sweating, involuntary muscle contractions, sensory disturbances, and confusion may be experienced.
With very large overdoses, exhaustion, seizures, low blood pressure leading to circulatory collapse or respiratory failure may occur.
What to do when the patient has taken more than the recommended dosage: In the event of accidental overdose, or if a child has eaten any, contact the doctor or nearest casualty department and show them the pack or leaflet. Nicotine Polacrilex Mini Lozenge is not suitable for children, who may develop signs of nicotine overdose. The general symptoms of nicotine overdose include headache, sickness, stomach pains and diarrhoea. If the patient uses too many nicotine lozenges, they may start to feel sick, dizzy and unwell. Stop using the lozenge and seek medical advice immediately.
Even small quantities of nicotine are dangerous in children and may result in severe symptoms of poisoning which may prove fatal. If poisoning is suspected in a child, consult a healthcare professional immediately.
Not to be taken by non-smokers.
Do not use if the patient is allergic to nicotine or any of the other ingredients in the lozenge.
Nicotine Polacrilex Mini Lozenge contains nicotine. When the patient sucks the lozenge, the nicotine is slowly released and absorbed through the lining of the mouth. The lozenge can alleviate some of the unpleasant withdrawal effects that frequently occur when giving up smoking, such as cravings and irritability.
The lozenge can reduce patient's desire to smoke and help improve their willpower to resist smoking by providing some of the nicotine previously inhaled. Nicotine Polacrilex Mini Lozenge is best suited for those with low nicotine dependency.
lt is not recommended for those who have found other forms of nicotine replacement therapy unsatisfactory. The nicotine dependence makes it difficult to stop smoking.
The craving for cigarettes can continue for some time after the patient has ceased smoking. The patient still needs to use their willpower to resist the urge to smoke. Advice and support will improve the patient's success.
Consult a doctor before using Nicotine Polacrilex Mini Lozenge: If the patient has diabetes they should monitor their blood sugar levels more often than usual when they start using nicotine lozenge. The patient's insulin or medication requirements may change.
If the patient had a recent heart attack, stroke or suffer from severe heart rhythm problems or chest pain, they should try to quit smoking without using any NRT products unless the doctor tells the patient to use them.
If the patient has any heart problems, they should consult a healthcare professional before using any NRT product. While using an NRT product, if the patient experiences an increase in heart problems, the use of the product should be reduced or discontinued.
If the patient suffers from kidney or liver disease.
If the patient has stomach or duodenal ulcers or an inflamed oesophagus or gullet (the passage between the mouth and stomach) because nicotine replacement therapy can make the symptoms worse.
If the patient has ever experienced seizures.
If the patient has an overactive thyroid gland.
If the patient has high blood pressure, angina or circulatory problems.
If the patient has a tumour of the adrenal gland (pheochromocytoma).
If the patient has inflammation of the mouth or sore throat.
If the patient is under 18 years of age, ask a doctor before use.
The effect of some medicines can be altered when the patient stops smoking. If the patient is already taking regular medication, they should tell a doctor or pharmacist.
If the patient is pregnant, they should stop smoking without using nicotine replacement therapy. However, if the patient has tried and this has not worked, nicotine replacement therapy should only be used upon advice by a healthcare professional to help the patient stop smoking.
If the patient is breastfeeding, nicotine replacement therapy should only be used upon advice by a healthcare professional because nicotine can pass into breastmilk.
After taking Nicotine Polacrilex Mini Lozenge some of the side effects the patient may encounter are (from most likely to least likely): Feeling sick (nausea); Dryness of the mouth; Cough; Insomnia; Vomiting; Dizziness and headache; Difficulty in swallowing; Constipation; Increased saliva production; Hiccups; Flatulence; Indigestion/heartburn; Diarrhea; Stomach discomfort; Being sick; Sore or swollen throat; The lozenges may cause the patient's mouth or tongue to be slightly sore or irritated; Shortness of breath; Fast or irregular heartbeat; Severe allergic reaction symptoms of which include sudden wheeziness or tightness of chest, rash and feeling faint.
Tell the doctor or pharmacist if the patient notices any other effect that they think might be caused by using the lozenge.
When should the patient consult a doctor: If symptoms persists, worsen or if new symptoms occur, patients should stop use and consult a doctor.
No clinically relevant interactions between nicotine replacement therapy and other drugs have been established.
Store below 30°C. Protect from direct heat and sunlight.
N07BA01 - nicotine ; Belongs to the class of drugs used in the management of nicotine dependence.
SKIIP loz 2 mg
((cherry flavor)) 10's; ((mint flavor)) 10's
SKIIP loz 4 mg
((cherry flavor)) 10's